Dr. Deepa Magge

About Dr. Magge

Deepa Magge, MD, FACS is an acclaimed mesothelioma doctor who specializes in treating mesothelioma.

She has over 10 years of experience and has spent much of that time with a special focus on peritoneal mesothelioma. This type of cancer forms in the abdominal lining 10-50 years after exposure to asbestos.

She is currently the Director of the Peritoneal Surface Malignancy/HIPEC Program at Nashville’s Vanderbilt-Ingram Cancer Center, which is part of Vanderbilt University Medical Center.

Download our Free Checklist of 14 Questions to Ask Your Doctor and find answers when you see Dr. Magee or another mesothelioma specialist.

Who Does Dr. Magge Treat?

Dr. Magge specializes in treating patients with peritoneal mesothelioma. This type of mesothelioma cancer affects the lining of the abdomen, which is called the peritoneum.

While peritoneal mesothelioma is life-threatening, surgery and other medical procedures can help some patients become long-term survivors.

Dr. Magge treats peritoneal mesothelioma using cytoreduction with hyperthermic intraperitoneal chemotherapy (HIPEC). This treatment combines surgery and chemotherapy and can help patients live for 53 months on average. Some who’ve had this treatment have gone on to live for 15 years or more.

“I always try to guide patients to not lose hope, regardless of what I am able or not able to do. The best and most important part of my job is providing that patient hope.”
–Dr. Deepa Magge, peritoneal mesothelioma specialist

In addition to treating mesothelioma, Dr. Magge treats colon cancer, rectal cancer, and other gastrointestinal cancers.

Dr. Magge also offers palliative mesothelioma therapies that aim to decrease patient pain and improve quality of life.

Dr. Magge’s Medical Background

Dr. Magge received her medical degree from Boston University in 2008, where she graduated with honors.

She followed this by completing her general surgery residency and complex surgery oncology fellowship at the University of Pittsburgh Medical Center (UPMC), during which she earned the role of Administrative Chief Fellow.

Dr. Magge then began her surgical oncology career at Mount Sinai Hospital in New York City, where she served as an assistant professor before joining the Vanderbilt team.

Dr. Magge’s Treatment Approach

Dr. Magge specializes in a combination of cytoreduction and HIPEC to treat peritoneal mesothelioma.

This two-step procedure involves:

1. Cytoreductive surgery, which is sometimes referred to as debulking and aims to remove all visible traces of a cancerous tumor from the abdominal lining.
2. HIPEC, a type of heated chemotherapy that aims to kill cancer cells that surgery couldn’t destroy. The abdomen is bathed in warm chemotherapy drugs immediately after cytoreductive surgery.

“I see my patients every 3-6 months for their entire life, so I get very close with them. I think that relationship is the most important thing for me.”
–Dr. Deepa Magge, peritoneal mesothelioma specialist

She also participates in cancer research and conducts clinical trials on new and improved treatments for peritoneal mesothelioma.

Connect with Dr. Magge and other top doctors to get the mesothelioma treatments you need using our Free Doctor Match.

Career Highlights

Dr. Magge is a highly accomplished doctor who has achieved national recognition and has held several leadership positions throughout her career.

Awards and Accolades

Dr. Magge has been recognized on many levels for her accomplishments as a professor and cancer specialist.

Some of her awards and accolades include:

• Anne and David Mishel Cancer Research Award
• Awarded role of Administrative Chief Fellow at UPMC
• Awarded role of Administrative Chief Resident during general surgery residency
• Resident Teaching Award
• Resident Research Award

Professional Affiliations

Dr. Magge also has a variety of medical certifications and affiliations.

These roles, memberships, and board certifications include:

• Assistant Professor of Surgery, Vanderbilt University Medical Center
• Assistant Professor of Surgery, Division of Surgical Oncology, Icahn School of Medicine, Mount Sinai
• Board-certified in general surgery and complex general surgical oncology by the American Board of Surgery
• Director of Peritoneal Surface Malignancy/HIPEC Program, Vanderbilt-Ingram Cancer Center

Research and Published Works

Dr. Magge has been published numerous times for her research on peritoneal mesothelioma and other gastrointestinal cancers.

“I focus on outcomes research. We do a lot of work with our HIPEC database and trying to figure out better treatment plans and better ways to manage patient outcomes.”
–Dr. Deepa Magge, peritoneal mesothelioma specialist

Some of her most recent contributions include:

• Downs-Canner, S., et al. “A comparative analysis of postoperative pancreatic fistulas after surgery with and without hyperthermic intraperitoneal chemoperfusion.” Published in the Annals of Surgical Oncology, May 2015.
• Hanna, N., et al. “Association of systemic chemotherapy approaches with outcomes in appendiceal peritoneal metastases.” Published in the Journal of Surgical Research, December 2022.
• Hanna, D.N., et al. “Impact of insurance status on oncologic and perioperative outcomes after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.” Published in the Annals of Surgical Oncology, January 2022.
• Magge, D., & Tan, M. “Disparities in Gastric Cancer: Can we do better?” Published in the Annals of Surgical Oncology, March 2021.
• Solomon, D., et al. “Signet ring cell features with peritoneal carcinomatosis in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy are associated with poor overall survival.” Published in the Journal of Surgical Oncology, May 2019.

Dr. Magge’s Work in Cancer Treatment & Research

Dr. Magge’s studies of peritoneal mesothelioma treatment have been published by major cancer research journals.

Peritoneal mesothelioma is a very rare and aggressive cancer, but thanks to the work that Dr. Magge and other mesothelioma doctors are doing, patients can rest assured they are in the best hands.

Further, more mesothelioma clinical trials (which study new and possibly better treatments) continue to be launched every year, in part thanks to the research conducted by specialists like Dr. Magge.

Dr. Magge has also served the medical profession by training future doctors and mesothelioma specialists.

To learn more about peritoneal mesothelioma, cancer research, and clinical trials, get our Free Mesothelioma Guide shipped overnight.

Get in Touch With Dr. Magge

If you want to get in touch with Dr. Magge or another cancer specialist after receiving a mesothelioma diagnosis, contact our team right now.

Mesothelioma Hope can connect you with top mesothelioma doctors. We can also help you find and afford the best mesothelioma treatments for your case.

To speak with one of our mesothelioma Patient Advocates today, call us at (866) 608-8933 or fill out our contact form.